In 1996 the SSA formed the Australasian Stroke Trial Network (ASTN). Its main aim is to facilitate participation of stroke units around Australasia in national and international multicentre therapeutic trials. This covers both industry-funded and investigator-driven research, and includes trials in both acute stroke treatment and secondary prevention.The ASTN is the coordinating body for stroke trial centres in Australasia and allows a professional interface between researchers/clinicians undertaking stroke trials and the pharmaceutical industry.
The ASTN currently includes 35 centres in Australia, New Zealand, Singapore and Hong Kong.
The chief aim of the network is to ensure a coordinated strategy for involvement of the Australasian Pacific region in International Stroke Trials and to facilitate optimal communication and collaboration between centres in our region.